Cargando…
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
Direct healthcare costs for patients with asthma are less than half (−52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388176/ https://www.ncbi.nlm.nih.gov/pubmed/37529638 http://dx.doi.org/10.1183/23120541.00158-2023 |